These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 12795780)
1. Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors. Wang RB; Kuo CL; Lien LL; Lien EJ J Clin Pharm Ther; 2003 Jun; 28(3):203-28. PubMed ID: 12795780 [TBL] [Abstract][Full Text] [Related]
2. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure-activity relationships. Bai J; Zhao S; Fan X; Chen Y; Zou X; Hu M; Wang B; Jin J; Wang X; Hu J; Zhang D; Li Y Toxicol Appl Pharmacol; 2019 Apr; 369():49-59. PubMed ID: 30790579 [TBL] [Abstract][Full Text] [Related]
4. Marine Natural Products as Models to Circumvent Multidrug Resistance. Long S; Sousa E; Kijjoa A; Pinto MM Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665 [TBL] [Abstract][Full Text] [Related]
5. Arylamino Esters As P-Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity. Teodori E; Dei S; Floriddia E; Perrone MG; Manetti D; Romanelli MN; Contino M; Colabufo NA ChemMedChem; 2015 Aug; 10(8):1339-43. PubMed ID: 26012726 [TBL] [Abstract][Full Text] [Related]
6. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR). Teodori E; Dei S; Martelli C; Scapecchi S Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921 [TBL] [Abstract][Full Text] [Related]
7. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators. Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123 [TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents. Pérez-Victoria JM; Di Pietro A; Barron D; Ravelo AG; Castanys S; Gamarro F Curr Drug Targets; 2002 Aug; 3(4):311-33. PubMed ID: 12102602 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein. Bain LJ; McLachlan JB; LeBlanc GA Environ Health Perspect; 1997 Aug; 105(8):812-8. PubMed ID: 9347896 [TBL] [Abstract][Full Text] [Related]
10. Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): recent biochemical and structural studies. Chufan EE; Sim HM; Ambudkar SV Adv Cancer Res; 2015; 125():71-96. PubMed ID: 25640267 [TBL] [Abstract][Full Text] [Related]
11. Multidrug transport by ATP binding cassette transporters: a proposed two-cylinder engine mechanism. van Veen HW; Higgins CF; Konings WN Res Microbiol; 2001; 152(3-4):365-74. PubMed ID: 11421284 [TBL] [Abstract][Full Text] [Related]
12. Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1). Pluchino KM; Hall MD; Moen JK; Chufan EE; Fetsch PA; Shukla S; Gill DR; Hyde SC; Xia D; Ambudkar SV; Gottesman MM Biochemistry; 2016 Feb; 55(7):1010-23. PubMed ID: 26820614 [TBL] [Abstract][Full Text] [Related]
13. Molecular factors influencing the affinity of flavonoid compounds on P-glycoprotein efflux transporter. Vázquez RN; Camargo AB; Marchevsky EJ; Luco JM Curr Comput Aided Drug Des; 2014; 10(3):250-8. PubMed ID: 25756670 [TBL] [Abstract][Full Text] [Related]
14. Cancer cell permeability-glycoprotein as a target of MDR reverters: possible role of novel dihydropyridine derivatives. Fusi F; Saponara S; Valoti M; Dragoni S; D'Elia P; Sgaragli T; Alderighi D; Kawase M; Shah A; Motohashi N; Sgaragli G Curr Drug Targets; 2006 Aug; 7(8):949-59. PubMed ID: 16918323 [TBL] [Abstract][Full Text] [Related]
15. Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives. Li XQ; Wang L; Lei Y; Hu T; Zhang FL; Cho CH; To KK Eur J Med Chem; 2015 Aug; 101():560-72. PubMed ID: 26197160 [TBL] [Abstract][Full Text] [Related]
16. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein. Chufan EE; Kapoor K; Ambudkar SV Biochem Pharmacol; 2016 Feb; 101():40-53. PubMed ID: 26686578 [TBL] [Abstract][Full Text] [Related]
17. Structure-Function Relationships in the Human P-Glycoprotein (ABCB1): Insights from Molecular Dynamics Simulations. Mora Lagares L; Pérez-Castillo Y; Minovski N; Novič M Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008783 [TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance transporters and modulation. Tan B; Piwnica-Worms D; Ratner L Curr Opin Oncol; 2000 Sep; 12(5):450-8. PubMed ID: 10975553 [TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Pérez-Tomás R Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in molecular modeling and medicinal chemistry aspects of phospho-glycoprotein. Srinivas E; Murthy JN; Rao AR; Sastry GN Curr Drug Metab; 2006 Feb; 7(2):205-17. PubMed ID: 16472108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]